pyrazines has been researched along with Severe Fever with Thrombocytopenia Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, N; Fang, LQ; Li, H; Li, JC; Liu, W; Lu, QB; Lv, SM; Peng, XF; Song, YB; Wang, HQ; Yang, T; Yao, WS; Yuan, C; Yuan, Y; Zhang, DN; Zhang, XA; Zhao, J | 1 |
| Azuma, T; Furumoto, A; Haku, T; Hidaka, M; Himeji, D; Ikeda, K; Ishida, M; Ishimaru, T; Kadowaki, N; Kakihana, Y; Kamikokuryo, C; Kaneko, M; Kawamura, M; Kurosu, T; Ohge, H; Saijo, M; Sakabe, S; Shimojima, M; Suemori, K; Takahashi, T; Takenaka, K; Taniguchi, T; Yamanaka, A; Yasukawa, M; Yoshikawa, T | 1 |
| Bai, JY; Cui, N; Dai, K; Du, J; Fan, H; Fan, XJ; Fang, LQ; Hao, ZN; Jiang, XM; Li, H; Li, JX; Liu, HZ; Liu, W; Lu, QB; Peng, K; Song, YB; Wang, HQ; Wang, J; Wang, Z; Wang, ZB; Xiao, G; Xin, QL; Yang, Y; Yang, ZD; Yuan, C; Yuan, L; Yuan, YM; Zhang, DN; Zhang, L; Zhang, LK; Zhang, SF; Zhang, XA | 1 |
2 trial(s) available for pyrazines and Severe Fever with Thrombocytopenia Syndrome
| Article | Year |
|---|---|
Clinical efficacy and safety evaluation of favipiravir in treating patients with severe fever with thrombocytopenia syndrome.
Topics: Aged; Amides; Antiviral Agents; Female; Humans; Male; Middle Aged; Pyrazines; Severe Fever with Thrombocytopenia Syndrome; Treatment Outcome; Viral Load | 2021 |
Clinical effect and antiviral mechanism of T-705 in treating severe fever with thrombocytopenia syndrome.
Topics: Administration, Oral; Amides; Animals; Antiviral Agents; Female; Humans; Male; Mice; Mice, Knockout; Middle Aged; Phlebovirus; Prospective Studies; Pyrazines; Severe Fever with Thrombocytopenia Syndrome; Single-Blind Method | 2021 |
1 other study(ies) available for pyrazines and Severe Fever with Thrombocytopenia Syndrome
| Article | Year |
|---|---|
A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome.
Topics: Adult; Aged; Aged, 80 and over; Amides; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Japan; Liver Diseases; Male; Middle Aged; Phlebovirus; Pyrazines; RNA, Viral; Severe Fever with Thrombocytopenia Syndrome; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Viral Load | 2021 |